Potential of Adenosine A Receptor Antagonists in the Treatment of Movement Disorders

Author： Mally J.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.10, Iss.5, 1998-11, pp. : 311-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galanin Receptor Antagonists: A Potential Novel Pharmacological Treatment for Mood Disorders

By Ögren Sven Ove   Kuteeva Eugenia   Hökfelt Tomas   Kehr Jan  

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 633-654

Adis International

Access to resources Recommend Favorite

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

By Bisaga A.   Popik P.   Bespalov A.Y.   Danysz W.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2233-2248

Informa Healthcare

Access to resources Recommend Favorite

A2B adenosine receptor antagonists and their potential indications

By Zablocki Jeff   Elzein Elfatih   Kalla Rao  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. : 1347-1357

Informa Healthcare

Access to resources Recommend Favorite

Adenosine type 1 receptor antagonists in fluid retaining disorders

By Welch William J  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1553-1562

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E.   Noll G.   Lüscher T.F.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite